Two-electrode voltage clamp

DN Daniel L. Neverisky
GA Geoffrey W. Abbott
request Request a Protocol
ask Ask a question
Favorite

Two-electrode voltage clamp (TEVC) recording was performed at room temperature with an OC-725C amplifier (Warner Instruments, Hamden, CT, USA) and pClamp8 software (Molecular Devices, Sunnyvale, CA, USA) 4 to 5 d after cRNA injection as described above. Oocytes were placed in a small-volume oocyte bath (Warner Instruments) and viewed with a dissection microscope. Bath solution was (mM): 96 NaCl, 4 KCl, 1 MgCl2, 1 CaCl2, and 10 HEPES (pH 7.6). Preincubations with cytochalasin D or wortmannin (Sigma-Aldrich) were performed in SBB storage solution (Ecocyte). Pipettes were of 1 to 2 MΩ resistance when filled with 3 M KCl. Currents were recorded in response to pulses between −80 and 40 or 60 mV at 10-mV intervals, or a single pulse to +40 mV, from a holding potential of −80 mV, to yield current–voltage relationships and current magnitude, and for quantifying the activation rate. TEVC data analysis was performed with Clampfit (Molecular Devices) and Origin 6.1 (OriginLab, Northampton, MA, USA) software; values are stated as means ± sem. Normalized tail currents were plotted vs. prepulse voltage and fitted with a single Boltzmann function according to the following equation:

where g is the normalized tail conductance, A1 is the initial value at −∞, A2 is the final value at +∞, V½ is the half-maximal voltage of activation, and Vs the slope factor. KCNQ2/3 activation at −40 mV was fit with a single exponential function. Where informative, currents were compared with one another using 1-way ANOVA to assess statistical significance (P < 0.05). If multiple comparisons were performed, a post hoc Tukey’s HSD test was performed after ANOVA.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A